Agios Pharmaceuticals, Inc. (AGIO) is a publicly traded Healthcare sector company. As of September 10, 2026, AGIO trades at $34.55 with a market cap of $2.00B and a P/E ratio of -4.94. AGIO moved -0.23% today. Year to date, AGIO is +27.22%; over the trailing twelve months it is -4.20%. Its 52-week range spans $22.24 to $46.00. Analyst consensus is buy with an average price target of $41.33. Rallies surfaces AGIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AGIO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $34.55 |
| Market Cap | $2.00B |
| P/E Ratio | -4.94 |
| EPS | $-7.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.00 |
| 52-Week Low | $22.24 |
| Volume | 3.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $54.03M |
| Net Income | $-412.78M |
| Gross Margin | 88.26% |
9 analysts cover AGIO: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $41.33.